Latest / Concord News Today | 2 Min News | The Daily News Now!
Rasonque Breaks Pancreatic Cancer Barriers | Concord News
A breakthrough pill called Rasonque is rewriting the odds for pancreatic cancer patients, nearly doubling survival rates and stopping tumor growth in over 80% of early trials. Where chemo offers just seven months, Rasonque extends life by more than a year — a stunning leap. Doctors are calling it a game-changer, and its potential may extend to other deadly cancers too. New Hampshire patients are among the first to access it via an early rollout, with global interest already pouring in. Nationwide availability is on the horizon, though pricing remains pending. Listen in comfort:Get a discount…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.